GlaxoSmithKline is reportedly considering whether to split its business into a consumer health spin-off and standalone pharmaceutical and vaccines group.
{iframe}http://www.pharmatimes.com/news/gsk_considers_splitting_up_1245326{/iframe}
About BioHealth Innovation
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
Connect
© 2025 BioHealth Innovation.